Evidence map›Paper›PMID 25664647›Full record

ArticleCell proliferation2015

IFI27, a novel epidermal growth factor-stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytes.

W-L Hsieh, Y-H Huang, T-M Wang, Y-C Ming, C-N Tsai, J-H S Pang

Abstract read
In one paragraph

Article in Cell proliferation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Bioinformatics analysis to reveal the potential comorbidity mechanism in psoriasis and nonalcoholic steatohepatitis.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Mouse Models of Psoriasis: A Comprehensive Review.The Journal of investigative dermatology · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

W-L HsiehGraduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Tao-Yuan City, 33302, Taiwan; Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Tao-Yuan City, 33302, Taiwan.
Y-H Huang
T-M Wang
Y-C Ming
C-N Tsai
J-H S Pang
Chang Gung University · TWBoston Children's Hospital · USChang Gung Memorial Hospital · TWMemorial Hospital of South Bend · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIFI27 is highly expressed in psoriatic lesions but its function has not been known. The present study aimed to explore its role in proliferation of epidermal keratinocytes. MATERIALS AND

methodsIFI27 knockdown and over-expression in keratinocytes were used to compare their proliferation, by MTT assay, apoptosis (by annexin V binding) and cell cycle progression by flow cytometry. Formation of cyclin A/CDK1 complex was examined by a co-immunoprecipitaion method. Anti-proliferation effects of IFI27 were also examined in vivo by topical application of IFI27 siRNA on imiquimod-induced psoriatic lesions, in a mouse model.

resultsEpidermal growth factor was demonstrated to increase IFI27 expression by prolonging half-life of IFI27 protein. The IFI27 knockdown in keratinocytes reduced the proliferation rate, but had no effect on apoptosis nor on apoptosis-related genes. Interestingly, IFI27 knockdown resulted in S-phase arrest that was found to be associated with increased Tyr15 phosphorylation of CDK1, reduced CDC25B and reduced formation of cyclin A/CDK1 complex. In addition, IFI27 knockdown was also shown to activate p53 by Ser15 phosphorylation and increase p21 expression. Topical application of IFI27 siRNA on imiquimod-induced psoriatic lesion in a mouse model reduced epidermal thickness, formation of rete ridges and PCNA expression.

conclusionsOur study demonstrates for the first time, that cell function of IFI27 is involved in proliferation of skin keratinocytes both in vitro and in vivo. It suggests that IFI27 might be a suitable target for development of a novel anti-psoriasis therapy.

Indexed as

AminoquinolinesAnimalsApoptosiscdc25 PhosphatasesCDC2 Protein KinaseCell ProliferationCells, CulturedCyclin ACyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent KinasesEnzyme ActivationEpidermal Growth FactorHumansImiquimodKeratinocytesMaleAminoquinolinesCDC25B protein, humancdc25 PhosphatasesCDC2 Protein KinaseCDK1 protein, humanCyclin ACyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent KinasesEpidermal Growth FactorIFI27 protein, humanImiquimodMembrane ProteinsMultiprotein ComplexesRNA, Small InterferingTumor Suppressor Protein p53

Identifiers

PMID25664647
PMCPMC6496262
OpenAlexW2007804011

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.